BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8928236)

  • 21. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device.
    Després D; Flohr T; Uppenkamp M; Baldus M; Hoffmann M; Huber C; Derigs HG
    J Hematother Stem Cell Res; 2000 Aug; 9(4):557-64. PubMed ID: 10982256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mobilization and selection of CD34-positive hematopoietic progenitors.
    Cagnoni PJ; Shpall EJ
    Blood Rev; 1996 Mar; 10(1):1-7. PubMed ID: 8861273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
    Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
    Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of hematopoietic stem cells.
    Fritsch G; Stimpfl M; Kurz M; Leitner A; Printz D; Buchinger P; Hoecker P; Gadner H
    Ann N Y Acad Sci; 1995 Dec; 770():42-52. PubMed ID: 8597381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
    Rowley SD; Loken M; Radich J; Kunkle LA; Mills BJ; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger WI
    Bone Marrow Transplant; 1998 Jun; 21(12):1253-62. PubMed ID: 9674860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive stem cell selection--basic science.
    Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
    Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies.
    Szmigielska-Kaplon A; Szemraj J; Hamara K; Robak M; Wolska A; Pluta A; Czemerska M; Krawczynska A; Jamroziak K; Szmigielska K; Robak T; Wierzbowska A
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):986-91. PubMed ID: 24680978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use.
    Bohbot A; Lioure B; Faradji A; Schmitt M; Cuillerot JM; Laplace A; Oberling F
    Bone Marrow Transplant; 1996 Feb; 17(2):259-64. PubMed ID: 8640176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
    Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
    Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
    Di Nicola M; Siena S; Bregni M; Peccatori F; Magni M; Ravagnani F; Zorzino L; Bonadonna G; Gianni AM
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():80-2. PubMed ID: 7516920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.
    Laughlin MJ; Christiansen NP; Herzig GP; Blumenson L; Bonney D; Stewart CC
    Cytometry; 1996 Dec; 26(4):235-42. PubMed ID: 8979021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
    Shpall EJ; Jones RB; Bearman SI; Franklin WA; Archer PG; Curiel T; Bitter M; Claman HN; Stemmer SM; Purdy M
    J Clin Oncol; 1994 Jan; 12(1):28-36. PubMed ID: 7505806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change of adhesion molecule expression on CD34(+) cells from bone marrow and peripheral blood during mobilization with combination of chemotherapy and G-CSF].
    Da WM; Zhang M; Zhang BL; Jin HJ; Yu L; Han XP; Jing Y; Zhao Y; Wu XX; Huang WR; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):240-2. PubMed ID: 12513794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.